[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338989-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338989-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","downregulation-of-smoc1-is-associated-with-progression-of-colorectal-traditional-serrated-adenomas-research-open-access","Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas - Research Open Access","","Aberrant DNA methylation is common in colorectal serrated lesions, and prior work identified frequent SMOC1 CpG island methylation in traditional serrated adenomas (TSAs) and colorectal cancers (CRCs) but rare methylation in sessile serrated lesions (SSLs). This study further characterizes SMOC1 expression in early colorectal lesions by immunohistochemistry across colorectal tumors and adjacent normal tissues. Results show SMOC1 abundance in normal colon and SSLs with significant downregulation in TSAs, advanced adenomas, and cancers, suggesting diagnostic and risk-prediction value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/downregulation-of-smoc1-is-associated-with-progression-of-colorectal-traditional-serrated-adenomas-research-open-access/338989/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/downregulation-of-smoc1-is-associated-with-progression-of-colorectal-traditional-serrated-adenomas-research-open-access/338989.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To further characterize SMOC1 expression in early colorectal lesions, building on prior findings about SMOC1 methylation in TSAs and CRCs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SMOC1 expression assessed?",{"text":68,"@type":64},"SMOC1 expression was analyzed by immunohistochemistry in a series of colorectal tumors and adjacent normal colonic tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship did the study find between SMOC1 levels and lesion progression?",{"text":72,"@type":64},"Higher SMOC1 expression was seen in normal colon and SSLs, while SMOC1 was significantly downregulated in TSAs, advanced adenomas, and cancers, supporting an association with progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338989,1790167989,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Aoki et al. BMCGastroenterology (2024) 24:91 [https://doi.org/10.1186/s12876-024-03175-1](https://doi.org/10.1186/s12876-024-03175-1)  \nBMC Gastroenterology  \n RESEARCH Open Access  \nDownregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas  \nHironori Aoki1,2,3†, Akira Takasawa4†, Eiichiro Yamamoto1†, Takeshi Niinuma 1, Hiro‑o Yamano5, Taku Harada 1,2, Toshiyuki Kubo5, Akira Yorozu1, Hiroshi Kitajima 1, Kazuya Ishiguro 1, Masahiro Kai 1, Akio Katanuma2, Toshiya Shinohara6, Hiroshi Nakase5, Tamotsu Sugai7, Makoto Osanai4 and Hiromu Suzuki1*  \nAbstract  \nBackground Aberrant DNA methylation is prevalent in colorectal serrated lesions. We previously reported  \nthat the CpG island of SMOC1 is frequently methylated in traditional serrated adenomas (TSAs) and colorectal cancers (CRCs) but is rarely methylated in sessile serrated lesions (SSLs) . In the present study, we aimed to further characterize the expression of SMOC1 in early colorectal lesions.  \nMethods SMOC1 expression was analyzed immunohistochemically in a series of colorectal tumors (n= 199)  \nand adjacent normal colonic tissues (n= 112) .  \nResults SMOC1 was abundantly expressed in normal colon and SSLs while it was significantly downregulated inTSAs, advanced adenomas and cancers. Mean immunohistochemistry scores were as follows: normal colon, 24 . 2; hyperplastic polyp (HP), 18. 9; SSL, 23 . 8; SSL with dysplasia (SSLD)/SSL with early invasive cancer (EIC), 15. 8; TSA, 5 .4; TSA with high grade dysplasia (HGD)/EIC, 4 . 7; non‑advanced adenoma, 21 .4; advanced adenoma, 11. 9; EIC, 10.9. Higher levels SMOC1 expression correlated positively with proximal colon locations and flat tumoral morphology, reflecting its abundant expression in SSLs. Among TSAs that contained both flat and protruding components, levels of SMOC1 expression were significantly lower in the protruding components.  \nConclusion Our results suggest that reduced expression of SMOC1 is associated with progression ofTSAs and con‑ ventional adenomas and that SMOC1 expression may be a biomarker for diagnosis of serrated lesions and risk predic‑ tion in colorectal tumors.  \nKeywords SMOC1, Colorectal cancer, Serrated lesion, Traditional serrated adenoma  \n†Hironori Aoki, Akira Takasawa and Eiichiro Yamamoto contributed equally to this work.  \n*Correspondence: Hiromu Suzuki [hsuzuki@sapmed.ac.jp](hsuzuki@sapmed.ac.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)‑ [mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nAoki et al. BMCGastroenterology (2024) 24:91  \nIntroduction  \nColorectal cancers (CRCs) are a heterogeneous family of diseases that develop through several d","cbCaiboQYMVkCMrR","https://ap.wps.com/l/cbCaiboQYMVkCMrR","pdf",1523802,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Colorectal cancer pathways and serrated lesions\n## Prior findings on SMOC1 methylation","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To further characterize SMOC1 expression in early colorectal lesions, building on prior findings about SMOC1 methylation in TSAs and CRCs.\"},{\"question\":\"How was SMOC1 expression assessed?\",\"answer\":\"SMOC1 expression was analyzed by immunohistochemistry in a series of colorectal tumors and adjacent normal colonic tissues.\"},{\"question\":\"What relationship did the study find between SMOC1 levels and lesion progression?\",\"answer\":\"Higher SMOC1 expression was seen in normal colon and SSLs, while SMOC1 was significantly downregulated in TSAs, advanced adenomas, and cancers, supporting an association with progression.\"}]","Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas - Research Open Access | PDF",1790027048,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50a3890da14d032dd835f6491f121983.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1f54f4f3833e0e0e5ce94de089b84e3.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/683356584eb5a1332bbd858c1e05847b.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dab678e5f978b9626c8b8fe9fd5c79f.webp",980,1301]